The Association Between Areca-nut Chewing Habit and Metabolic Syndrome
Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
Status
Sponsors
Taichung Veterans General Hospital
CLINICAL TRIAL: NCT02175524
BioSeek: NCT02175524
Keywords
Abstract
The purpose of this study is going to determine the odds ratio of metabolic syndrome (MS), the habit of areca nut chewing, antioxidant, and inflammatory status in oral and esophageal patients. The current study was designed as a case-control study. Patients proved to be oral and esophageal cancer and had the habit of areca nut chewing are defined as case group. Patients proved to be oral and esophageal cancer and did not have the habit of areca nut chewing are defined as control group. The participants' age, blood pressures, and smoking habits will be recorded. Body weight, height, waist, and hip circumferences will be measured. Fasting venous blood samples will be obtained to determine hematological parameters [i.e., serum creatinine, total cholesterol, triacylglycerol, low density lipoprotein-cholesterol, high density lipoprotein-cholesterol, malondialdehyde, superoxide dismutase, glutathione peroxidase, catalase, and inflammatory markers (C-reactive protein, tumor necrosis factor-alpha, and interleukin-6)]. Logistic regression analyses are going to perform to examine the relationship between areca nut chewing and MS in this population. If we can make sure the relationship between areca nut chewing and MS, the clinicians and nutritionists can teach people to quit areca nut chewing in order to avoid the possibility of developing metabolic syndrome and cardiovascular disease.
Dates
Last Verified: | 05/31/2014 |
First Submitted: | 06/23/2014 |
Estimated Enrollment Submitted: | 06/23/2014 |
First Posted: | 06/25/2014 |
Last Update Submitted: | 06/23/2014 |
Last Update Posted: | 06/25/2014 |
Actual Study Start Date: | 03/31/2014 |
Estimated Primary Completion Date: | 11/30/2017 |
Condition or disease
Oral and Esophageal Cancer
Metabolic Syndrome.
Phase
-
Arm Groups
Arm | Intervention/treatment |
---|---|
Case Patients proved to be oral and esophageal cancer and had the habit of areca nut chewing. | |
Control Patients proved to be oral and esophageal cancer and did not have the habit of areca nut chewing. |
Eligibility Criteria
Ages Eligible for Study | 20 Years To 20 Years |
Sexes Eligible for Study | All |
Sampling method | Non-Probability Sample |
Accepts Healthy Volunteers | Yes |
Criteria | Inclusion Criteria: - Patients proved to be oral and esophageal cancer will be recruited. Exclusion Criteria: - Subjects with diabetes mellitus, liver, renal diseases, or undergoing statin therapy. - Taking antioxidant vitamins supplements. |
Outcome
Primary Outcome Measures
1. Metabolic syndrome [Up to 1 week]
Measure blood pressure, blood lipid profiles, fasting glucose, and waist circumferences.
Secondary Outcome Measures
1. Antioxidant activity [Up to 1 week]
Antioxidant ability measurements: lipid peroxidation markers (MDA), antioxidant enzymes activities (catalase, glutathione peroxidase, and superoxide dismutase).
2. Inflammatory status [Up to 1 week]
Measure inflammatory markers: C-reactive protein, Interleukin-6, and tumor necrosis factor-alpha.